Tablets & Capsules Magazine

2 weeks ago | tabletscapsules.com | Mike Auerbach

Cleaning validation is a critical aspect of pharmaceutical manufacturing, particularly for facilities producing oral solid dosage forms. This process ensures that equipment and facilities are free from residues that could contaminate subsequent batches, potentially compromising product quality and patient safety.

3 weeks ago | tabletscapsules.com | Mike Auerbach

The pharmaceutical capsule industry is experiencing a renaissance, driven by technological advancements, evolving patient needs and stringent regulatory requirements. The capsules sector, which already offers several known advantages over tablets, is wellpositioned to meet the growing demands of modern health care. From AI-driven filling machines to vegan capsule alternatives, the sector continues to embrace new innovations.

1 month ago | tabletscapsules.com | Karen Langhauser

Throughout history, humans have sought to ‘encapsulate’ time, preserving pieces of the present for the future. Credit for the term ‘time capsules’ is largely given to editor-turned-public-relations specialist George Pendray, who proposed the idea of burying a cross-section of contemporary time in a metal tube as part of a publicity campaign for the Westinghouse Electric and Manufacturing Company at the 1939 New York World’s Fair. The idea, however, was borrowed.

1 month ago | tabletscapsules.com | Mike Auerbach

Titanium dioxide (TiO₂), an inorganic chemical substance, has long been a crucial excipient in pharmaceutical tablets, serving as an opacifier and white colorant. However, recent developments have raised concerns about its safety and prompted a search for alternatives. The European Union banned the use of titanium dioxide (grade E171) as a food additive in 2022 due to safety concerns.

2 months ago | tabletscapsules.com | Karen Langhauser

The new year is in full swing. In the U.S., the oral solid dose sector has already put up some regulatory wins and has a handful of key decisions waiting in the wings. The industry’s most established and most favored dosage forms are coming off a strong 2024. Last year, the Center for Drug Evaluation and Research (CDER) approved a total of 50 new drugs, 40% of which were OSD formulations — 14 tablets and six capsules.